Shree Ganesh Remedies Limited (BOM:540737)

Market Cap	5.67B -38.3%
Revenue (ttm)	1.01B -17.6%
Net Income	180.82M -36.5%
EPS	14.08 -36.5%
Shares Out	12.84M
PE Ratio	31.38
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,263
Average Volume	3,947
Open	463.10
Previous Close	466.40
Day's Range	440.00 - 483.55
52-Week Range	381.10 - 828.00
Beta	0.00
RSI	36.50
Earnings Date	May 21, 2026

About Shree Ganesh Remedies

Shree Ganesh Remedies Limited engages in the manufacture and sale of pharmaceutical drug intermediates for active pharmaceutical ingredient (API) and fine chemicals in India and internationally. The company offers anti-arrhythmic, anti-cancer, anti-depressant, anti-diabetic, anti-diarrheal, antifungal, antihistamine, anti-inflammatory, anti-parasitic, anti-psychotic, anticholinergic, birth-control, cardiovascular, gastrointestinal, neurological disorder, ophthalmic, opioid, and veterinary API intermediates. It also provides fine and specialty c...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1995
• Employees: 149
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 540737

Financial Performance

In fiscal year 2025, Shree Ganesh Remedies's revenue was 1.09 billion, a decrease of -13.74% compared to the previous year's 1.26 billion. Earnings were 230.68 million, a decrease of -17.93%.